DMAE AS SOLE AGENT FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT
    1.
    发明申请
    DMAE AS SOLE AGENT FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT 有权
    DMAE作为治疗小儿认知障碍的唯一代理

    公开(公告)号:US20090298908A1

    公开(公告)日:2009-12-03

    申请号:US12447816

    申请日:2007-10-31

    IPC分类号: A61K31/4015 A61K31/13

    CPC分类号: A61K31/133

    摘要: The present invention relates to the use, as sole active ingredient, of dimethylaminoethanol (DMAE) in free form or in the form of salts or of esters and also of hydrates and solvates thereof, for the manufacture of a medicament for use in the treatment of a non-dementia mild cognitive impairment characterized by an amnestic syndrome of hippocampal type.

    摘要翻译: 本发明涉及作为唯一活性成分的游离形式或盐或酯形式的二甲基氨基乙醇(DMAE)以及其水合物和溶剂合物的用途,用于制备用于治疗 以痴呆症轻度认知障碍为特征的遗忘综合征海马型。